🔥Telegram İfşa

Excited to have Dr. David Huang (the recent Lasker Foundation awardee for his invention of OCT) to give us a ground round at UC San Francisco ophthalmology today!

Hot off the press! Although previous retrospective studies suggested that oral metformin has protective effects against AMD, our randomized controlled trial did not find a significant impact of oral metformin on geographic atrophy progression. AAO ophthalmologyscience.org/article/S2666-…

Editorial: To Treat or Not to Treat Geographic Atrophy – That is the Question ow.ly/W8G950QKKlK

I am extremely sad to hear that my mentor and role model, Professor Joseph Izatt, passed away yesterday. He is a giant in engineering and ophthalmology, and has inspired countless of trainees. It’s such a tragedy to the field. today.duke.edu/2024/04/duke-f…

Looking forward to presenting our work on #choroideremia and #AOSLO at 1:30 pm on Sunday in room 612 at Seattle Convention Center #ARVO2024 @RoordaLab

The National Eye Institute is crucial for eye health innovation. Energy and Commerce Committee must keep NEI independent to continue its work for patients. We urge Congress to boost NEI funding and improve vision health for Americans. ow.ly/EtI850T7VmW #EyeCareAdvocacy

Our latest study Ophthalmology shows that increased baseline hyperautofluorescent signals (rim area focal hyperautofluorescence) is linked to faster geographic atrophy progression, particularly in small to medium-sized lesions. #AAO #Ophthalmology #GA ophthalmologyscience.org/article/S2666-…

Our latest review Annual Reviews, led by Eleonora Lad, MD, PhD, delves into functional and anatomical endpoints in #GeographicAtrophy clinical trials, explores the gap between structural and functional outcomes, and highlights key prognostic factors. We also provide recommendations for

Excited to present a paper at #AAO2024 this Sunday. I’ll be sharing our findings on key factors contributing to visual acuity decline in patients with GA, and discussing which patients may benefit their visual acuity most from therapies that slow GA progression. AAO

#AAO2024: In eyes with #GeographicAtrophy (GA), the amount of sharp vision a patient loses may depend on closeness of the lesion to #FovealCenter, level of baseline #BestCorrectedVisualAcuity (BCVA), and pace of GA growth. AAO Presented by Linus Shen, MD. Read more:

Association of Hyperautofluorescence Signals with Geographic Atrophy Progression in the METforMIN Trial ow.ly/9crO50TweZn #ophthalmology

I’m thrilled to share that I’ve matched into my first-choice vitreoretinal surgery fellowship at Duke! The first photo was taken 10 years ago, when I was an undergraduate at Duke assisting with intraoperative OCT that we developed and observing Dr. Cynthia Toth teach retina

🚨 New Publication Alert! 🚨 Our first paper of the year is out in Ophthalmology Ophthalmology! We analyzed 1351 eyes with geographic atrophy (GA) from AREDS & AREDS2 over 4 years to uncover key drivers of BCVA decline: 🔹 Baseline BCVA 🔹 GA proximity to the foveal center 🔹 GA

Determinants of Four-Year Visual Acuity Loss in Geographic Atrophy – An Analysis of AREDS and AREDS2 aaojournal.org/article/S0161-… Linus Shen, MD #ophthalmology

Liangbo Linus Shen et al. Linus Shen, MD UC San Francisco share their Longitudinal Assessment of Cone Structure, Choriocapillaris, and Retinal Sensitivity in Choroideremia, iovs.arvojournals.org/article.aspx?a….